| Recommendation 6.1 | Quality of the Evidence | Strength of recommendation |
| We suggest using low-dose haloperidol for the treatment of POD if nonpharmacological measures fail. We advise a short-term, symptom-oriented therapy. The application should be bolus-wise and with the lowest dose possible. Use antipsychotic drugs with caution or not at all for people with preexisting neurologic conditions, such as Parkinson's disease or Lewy bodies dementia. |
Very low RCT: Fukata et al., 2017 204/SR: Shen et al., 2018207 |
Weak |